Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Georg Wirsching

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Therapeutische Umschau. Revue Therapeutique|April 3, 2019
[Update on primary brain tumours]Hans-Georg Wirsching, Michael Weller
Trends in Cancer|January 19, 2020
Does Neuronal Activity Promote Glioma Progression?Hans-Georg Wirsching, Michael Weller
Current Treatment Options in Oncology|August 10, 2016
The Role of Molecular Diagnostics in the Management of Patients with GliomasHans-Georg Wirsching, Michael Weller
Advances in Experimental Medicine and Biology|July 11, 2023
Immunotherapy for MeningiomasHans-Georg Wirsching, Michael Weller
Handbook of Clinical Neurology|March 8, 2016
GlioblastomaHans-Georg Wirsching, Evanthia Galanis, Michael Weller
Expert Opinion on Therapeutic Targets|January 23, 2021
A vasculature-centric approach to developing novel treatment options for glioblastomaHans-Georg Wirsching, Patrick Roth, Michael Weller
Cancers|July 2, 2021
Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS LymphomaHans-Georg Wirsching, Michael Weller, Stefan Balabanov, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 5, 2020
Socioeconomic burden and quality of life in meningioma patientsHans-Georg Wirsching, Corinne Morel, Patrick Roth, et al.
Current Opinion in Oncology|September 24, 2015
Management of diffusely infiltrating glioma in the elderlyHans-Georg Wirsching, Caroline Happold, Patrick Roth, et al.
Nature Reviews. Clinical Oncology|December 30, 2016
Advances in the molecular genetics of gliomas - implications for classification and therapyGuido Reifenberger, Hans-Georg Wirsching, Christiane B Knobbe-Thomsen, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Therapeutische Umschau. Revue Therapeutique|April 3, 2019
[Update on primary brain tumours]Hans-Georg Wirsching, Michael Weller
Trends in Cancer|January 19, 2020
Does Neuronal Activity Promote Glioma Progression?Hans-Georg Wirsching, Michael Weller
Current Treatment Options in Oncology|August 10, 2016
The Role of Molecular Diagnostics in the Management of Patients with GliomasHans-Georg Wirsching, Michael Weller
Advances in Experimental Medicine and Biology|July 11, 2023
Immunotherapy for MeningiomasHans-Georg Wirsching, Michael Weller
Handbook of Clinical Neurology|March 8, 2016
GlioblastomaHans-Georg Wirsching, Evanthia Galanis, Michael Weller
Expert Opinion on Therapeutic Targets|January 23, 2021
A vasculature-centric approach to developing novel treatment options for glioblastomaHans-Georg Wirsching, Patrick Roth, Michael Weller
Cancers|July 2, 2021
Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS LymphomaHans-Georg Wirsching, Michael Weller, Stefan Balabanov, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 5, 2020
Socioeconomic burden and quality of life in meningioma patientsHans-Georg Wirsching, Corinne Morel, Patrick Roth, et al.
Current Opinion in Oncology|September 24, 2015
Management of diffusely infiltrating glioma in the elderlyHans-Georg Wirsching, Caroline Happold, Patrick Roth, et al.
Nature Reviews. Clinical Oncology|December 30, 2016
Advances in the molecular genetics of gliomas - implications for classification and therapyGuido Reifenberger, Hans-Georg Wirsching, Christiane B Knobbe-Thomsen, et al.
Pageof 6